Physician profile
Holman Chan
NPI 1255619177
$75,219.23
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 81% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $6,535 · 2021: $4,437 · 2022: $14K · 2023: $17K · 2024: $3,907 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $8,436 · Food and Beverage: $3,999 · Royalty Or License: $2,626 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,800.00 |
| Travel and Lodging | $8,436.37 |
| Food and Beverage | $3,998.63 |
| Royalty Or License | $2,626.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $35,163.95 | 2019-2025 | Axsos, T2 Alpha, Variax |
| Extremity Medical | $28,513.00 | 2019-2025 | Omni, Omni Mtp |
| Goode Surgical INC | $8,246.46 | 2019-2025 | |
| Arthrex, INC. | $2,192.98 | 2020-2025 | |
| Flower Orthopedics Coporation | $176.53 | 2023 | |
| Abbott Laboratories | $175.86 | 2022 | |
| Orthofix Medical, INC. | $150.65 | 2019-2021 | |
| Smith+Nephew, INC. | $106.95 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System |
| Si-Bone, INC. | $73.54 | 2023 | |
| Wright Medical Technology, INC. | $65.46 | 2020 | |
| Zimmer Biomet Holdings, INC. | $60.65 | 2021 | |
| Zimvie INC. | $44.15 | 2022 | |
| Avita Medical Americas, LLC | $36.70 | 2025 | Permeaderm, Recell, Cohealyx |
| Amgen INC. | $33.97 | 2024 | Krystexxa |
| Biocomposites INC | $31.47 | 2025 | Stimulan |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $31.03 | 2025 | Senza |
| Nevro Corp. | $30.37 | 2022 | |
| Acera Surgical, INC. | $26.01 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $24.25 | 2023 | |
| Ethicon US, LLC | $21.37 | 2024 | Dermabond Prineo |
| Bioventus LLC | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holman Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.